3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
15
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
4
Uveal Melanoma
3
Sarcoma
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous-Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Diseases
1
Osteosarcoma
1
Neoplastic Cells, Circulating
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Nasopharyngeal Carcinoma
1
Metastatic Microsatellite Stable Colorectal Cancer
1
Kidney Neoplasms
1
Hypoxia
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Interventions
Blood Specimen Collection
4
Liquid Biopsy
2
cabazitaxel
1
Sevoflurane
1
Radiotherapy
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Needles
1
Microfluidics
1
Lymph Node Excision
1
Leucovorin
1
Laparoscopy
1
Ipilimumab
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Ethiodized Oil
1
Epirubicin
1
Drug Therapy
1
Diagnostic Imaging
1
Circulating Tumor DNA
1
Chemoembolization, Therapeutic
1
Cell-Free Nucleic Acids
1
Capecitabine
1
CA-72-4 antigen
1
CA-19-9 Antigen
1
Biopsy, Fine-Needle
1
Aspirin
1
Antiemetics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplastic Cells, Circulating
×
Ipilimumab
×
Clear all
NCT01565837
2016-02-01
SART
Comprehensive Cancer Centers of Nevada
Phase 2
Unknown
50 enrolled